{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-184765","form_type":"8-K","ticker":"TXMD","cik":"0000025743","company_name":"TherapeuticsMD, Inc.","filed_at":"2023-07-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:36.202265+00:00","generated_at":"2026-06-13T10:45:29.503386+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"TherapeuticsMD dismisses Grant Thornton, engages BPB; prior reports had going concern note","bullets":["Grant Thornton dismissed as independent auditor on July 7, 2023; Berkowitz Pollack Brant appointed.","GT's reports for FY 2022 and 2021 included an explanatory paragraph on going concern uncertainty.","No disagreements with GT on accounting principles or audit scope; no reportable events occurred.","Audit change resulted from a request for proposal process."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-184765","json":"https://secwatch.observer/filing/0001193125-23-184765.json","markdown":"https://secwatch.observer/filing/0001193125-23-184765.md","text":"https://secwatch.observer/filing/0001193125-23-184765.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/25743/000119312523184765/0001193125-23-184765-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/25743/000119312523184765/d523471d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T10:45:29.503386+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"36236c6a63ad6f57b43964b56ca0e2e95767a85f","claim":"TherapeuticsMD, Inc. engaged Berkowitz Pollack Brant as its auditor.","evidence_excerpt":"engaged Berkowitz Pollack Brant (\"BPB\") as the Company’s independent registered public accounting firm for the 2023 fiscal year","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/25743/000119312523184765/0001193125-23-184765-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"engagement"},{"label":"Auditor","value":"Berkowitz Pollack Brant"}],"fact_type":"auditor_change"},{"claim_id":"b6aebbe99a6e6b9ee8c0700434d64c4b0a103b0c","claim":"TherapeuticsMD, Inc. dismissed Grant Thornton LLP as its auditor.","evidence_excerpt":"dismissed Grant Thornton LLP (\"GT\") as the Company’s independent registered public accounting firm","evidence_source":"SEC 8-K Item 4.01/4.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/25743/000119312523184765/0001193125-23-184765-index.htm","confidence":0.9,"family_label":"Auditor Changes","details":[{"label":"Action","value":"dismissal"},{"label":"Auditor","value":"Grant Thornton LLP"},{"label":"Successor","value":"Berkowitz Pollack Brant"}],"fact_type":"auditor_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}